Brookwood Internal Medicine Pc is categorized under Internal Medicine Doctors in Birmingham, AL and active since 2004.
Brookwood Internal Medicine Pc was established in 2004, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Charles B Crow at the company’s single location by writing to 2017 Canyon Road # 39, Birmingham, Alabama AL 35216 or by phoning (205) 871-7746. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Brookwood Internal Medicine Pc |
Contact Person: | Charles B Crow |
Address: | 2017 Canyon Road # 39, Birmingham, Alabama 35216 |
Phone Number: | (205) 871-7746 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Brookwood Internal Medicine Pc was started in 2004 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Charles B Crow for inquiries that concern Brookwood Internal Medicine Pc by calling the company number (205) 871-7746, as your correspondence is most welcome. Additionally, the physical location of the single location of Brookwood Internal Medicine Pc can be found at the coordinates 33.445164,-86.790398 as well as the street address 2017 Canyon Road # 39 in Birmingham, Alabama 35216.
For its online presence, you may visit Brookwood Internal Medicine Pc’s website at and engage with its social media outlets through on Twitter and on Facebook.